Apratastat is a potent, orally bioavailable dual inhibitor of TACE and MMPs, effectively suppressing TNF-alpha release. It demonstrates significant activity in vitro, ex vivo, and in vivo models, making it a valuable research tool for studying inflammatory and autoimmune diseases, cancer, and tissue remodeling processes.
Molekulargewicht:
414.5
CAS Nummer:
[287405-51-0]
Formel:
C17H22N2O6S2
Target-Kategorie:
MMP,TNF
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten